Stock Events

CytomX Therapeutics (CTMX) Q2 2024 Earnings

8MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.2
-0.08
0.05
0.17

Details

Expected EPS
-0.102071
Actual EPS
0.17
Surprise EPS
0.27
Surprise Percent
+266.55%

Description

CytomX Therapeutics (CTMX) has reported earnings of 0.17 per share for Q2 2024.

0 Comments

Share your thoughts